Health Care/Hospital

Transcenta Announces First Patient Dosed in Phase I China Trial of Claudin18.2 Targeting Monoclonal Antibody TST001

SUZHOU, China, Aug. 31, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced today that the first subject has been dosed successful...

2020-08-31 23:00 1268

Harbour BioMed Will Present Its New Platform HBICE (Heavy chain only antibody (HCAb) Based Immune Cell Engager) at 16th PEGS Boston Summit

SHANGHAI, Aug. 31, 2020 /PRNewswire/ -- Harbour BioMed, a global, clinical-stage, innovative biopharmaceutical company, today announced that it presented  its newly developed  HBICETM (HCAb Based Immune Cell Engager) platform and its ability to generate fast and reliable next-generation bispecif...

2020-08-31 21:39 2304

WAT Medical Enterprise Contributes to M.D. Anderson Cancer Center

VANCOUVER, BC, Aug. 31, 2020 /PRNewswire/ -- WAT Medical Enterprise has been supporting the world's cancer research. They donated part of the profits from selling EmeTerm on Amazon to the M.D. Anderson Cancer Center to support the development of global cancer. After making the donation in August ...

2020-08-31 21:30 1120

Capsa Healthcare Introduces the Trio™ Mobile Computing Workstation to Advance Nursing Performance in Any Healthcare Environment

PORTLAND, Oregon, Aug. 31, 2020 /PRNewswire/ -- Capsa Healthcare today announced the launch of the new Trio™ mobile computing workstation. Trio is Capsa's latest generation point-of-care platform to mobilize e-health records and support efficient and accurate medication management.

2020-08-31 21:12 1932

Concord Medical Announces Cooperation with Macao Kiang Wu hospital

BEIJING, Aug. 31, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone ...

2020-08-31 19:00 5146

I-Mab Reports Financial Results for the Six Months Ended June 30 and Provides Corporate Update

Positive preliminary clinical trial results for lemzoparlimab (TJC4) demonstrate a differentiated drug profile in safety and pharmacokinetics in cancer patients Joined the global effort against COVID-19 with plonmarlimab (TJM2) study which represents the first double-blind, placebo-controlled st...

2020-08-31 19:00 12851

Concord Medical Announces a Topping Out Ceremony of Shanghai Concord Cancer Center

BEIJING, Aug. 31, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone ...

2020-08-31 18:59 10623

Digital assistants, biometrics and virtual reality identified as key technologies for transformation, finds KPMG annual survey

HONG KONG, Aug. 31, 2020 /PRNewswire/ -- A majority (77%) of global technology executives are optimistic that innovative technologies such as digital assistants, biometrics and virtual reality will help improve their business models and achieve their goals, according to KPMG's annual survey. In ...

2020-08-31 16:38 2180

AXA launches new "MultiPro Critical Illness Protection" series

HONG KONG, Aug. 31, 2020 /PRNewswire/ -- Cancer, heart disease and cerebrovascular diseases are three of the most common fatal diseases in Hong Kong[1]. With advancements in medical technology, the mortality of these critical illnesses has reduced, but it is still difficult to avoid the recurren...

2020-08-31 14:04 3824

CStone Receives US FDA IND Clearance for CS1001-201 Study to Evaluate Anti-PD-L1 Monoclonal Antibody Sugemalimab Monotherapy in R/R ENKTL

SUZHOU, China, Aug. 31, 2020 /PRNewswire/ -- CStone Pharmaceuticals (SUZHOU) Co., Ltd. ("CStone", HKEX: 2616) today announced that the US Food and Drug Administration (FDA) has completed their review of the Investigational New Drug (IND) application for anti-PD-L1 monoclonal antibody sugemalimab ...

2020-08-31 11:35 2161

GenScript Reports 2020 Interim Results and Provides Business Update

NANJING, China, Aug. 31, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a leading global biotechnology company, today reported interim results for the six months endedJune 30, 2020 and provided a corporate update. Revenue of the Group for the six months endedJune 30, 2020 was...

2020-08-31 11:32 10051

Shandong stages welcoming event for Europe's Fortune 500 companies

JINAN, China, Aug. 30, 2020 /PRNewswire/ -- The "Connecting Shandong with Fortune Global 500" series of events, hosted by the CPC Shandong Provincial Committee and Shandong Provincial People's Government, organized by the Department of Commerce ofShandong Province, and sponsored by FORTUNE CHINA,...

2020-08-31 10:42 1365

Texas Cardiac Arrhythmia Institute physicians participate in clinical trial for 4D imaging technology for complex heart procedures

AUSTIN, Texas, Aug. 31, 2020 /PRNewswire/ -- Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center are among the first in the world to participate in a clinical trial to evaluate a new intra-cardiac echocardiography catheter.Andrea Natale, M.D., F.H.R.S., F.A...

2020-08-31 10:08 1748

Texas Cardiac Arrhythmia Institute physicians studying role of wearable devices, app for remote monitoring of cardiac rhythm disorders

Digital monitoring platform provides community support, access to healthcare providers to help patients implement recommended lifestyle changes AUSTIN, Texas, Aug. 31, 2020 /PRNewswire/ -- Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center are testing a n...

2020-08-31 09:08 1626

Genesis MedTech Acquires World-first Drug-coated Balloon Technology with Next-generation Angioplasty Architecture for the Treatment of Peripheral Vascular Diseases

SINGAPORE, Aug. 31, 2020 /PRNewswire/ -- Genesis MedTech International has completed the acquisition of the Chocolate Touch ® drug-coated balloon (DCB), a drug-device technology asset from TriReme Medical LLC, a wholly-owned subsidiary ofSingapore-listed QT Vascular Ltd, which engages in the desi...

2020-08-31 09:00 9009

Innovent Announces the Results of the Phase 1/2 Clinical Study of PCSK9 Antibody Tafolecimab at the European Society of Cardiology Annual Conference

SAN FRANCISCO and SUZHOU, China, Aug. 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune a...

2020-08-31 08:00 3815

G-ray Switzerland announces new CEO, closes successful funding round

NEUCHÂTEL, Switzerland, Aug. 31, 2020 /PRNewswire/ -- G-ray Switzerland, the medical imaging and industrial diagnosis start-up founded in 2014, has announced the appointment of Luis Pallares as Chief Executive Officer, as the company embarks on an accelerated growth drive and completes a successf...

2020-08-31 06:00 2160

Million-selling Erba COVID-19 antibody tests now validated on leading ELISA analysers

LONDON, Aug. 31, 2020 /PRNewswire/ -- To improve global availability of high-quality testing methods for SARS-CoV-2,Erba Mannheim announced the availability of validated automated protocols for their successful range of ErbaLisa COVID-19 IgG and IgM ELISA kits. Optimised protocols for popular ins...

2020-08-31 06:00 2177

Chiropractic Management for The Most Complicated Wry Neck, a Study by Hong Kong Chiropractors

HONG KONG, Aug. 30, 2020 /PRNewswire/ -- A bad night's sleep can lead to waking up with a painful neck, which makes it hard to turn your head. Wry neck often goes away without treatment. However,a study led by Eric Chu, chairman of Chiropractic Doctors Association ofHong Kong indicates that this ...

2020-08-30 22:06 2157

Changsha Haike, a HYCOR Biomedical Partner, Announces Registration From China HMPA for the ALLEOS™ 2000 System

GARDEN GROVE, California, Aug. 29, 2020 /PRNewswire/ -- HYCOR Biomedical, a leading manufacturer ofin vitro diagnostic products for allergy testing, and Changsha Haike Biotechnology Co., Ltd., its Chinese manufacturing partner, announced registration from Hunan Medical Products Administration ...

2020-08-29 05:03 4396
1 ... 13141516171819 ... 890